Logo image of CTAC.AS

CTAC NV (CTAC.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:CTAC - NL0000345577 - Common Stock

3.22 EUR
-0.09 (-2.72%)
Last: 12/5/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CTAC. CTAC was compared to 77 industry peers in the IT Services industry. CTAC has an average financial health and profitability rating. CTAC scores decently on growth, while it is valued quite cheap. This could make an interesting combination. CTAC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CTAC had positive earnings in the past year.
CTAC had a positive operating cash flow in the past year.
CTAC had positive earnings in each of the past 5 years.
In the past 5 years CTAC always reported a positive cash flow from operatings.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

CTAC has a better Return On Assets (5.74%) than 67.12% of its industry peers.
With a Return On Equity value of 13.36%, CTAC perfoms like the industry average, outperforming 58.90% of the companies in the same industry.
CTAC has a Return On Invested Capital (7.06%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CTAC is significantly below the industry average of 26.09%.
Industry RankSector Rank
ROA 5.74%
ROE 13.36%
ROIC 7.06%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CTAC has a Profit Margin (3.28%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CTAC has grown nicely.
CTAC has a Operating Margin of 4.54%. This is in the lower half of the industry: CTAC underperforms 60.27% of its industry peers.
CTAC's Operating Margin has improved in the last couple of years.
CTAC's Gross Margin of 54.86% is on the low side compared to the rest of the industry. CTAC is outperformed by 61.64% of its industry peers.
In the last couple of years the Gross Margin of CTAC has declined.
Industry RankSector Rank
OM 4.54%
PM (TTM) 3.28%
GM 54.86%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CTAC is still creating some value.
Compared to 1 year ago, CTAC has about the same amount of shares outstanding.
CTAC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CTAC has been reduced compared to a year ago.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CTAC has an Altman-Z score of 3.00. This indicates that CTAC is financially healthy and has little risk of bankruptcy at the moment.
CTAC has a better Altman-Z score (3.00) than 61.64% of its industry peers.
A Debt/Equity ratio of 0.37 indicates that CTAC is not too dependend on debt financing.
CTAC's Debt to Equity ratio of 0.37 is fine compared to the rest of the industry. CTAC outperforms 60.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 3
ROIC/WACC1.08
WACC6.54%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

CTAC has a Current Ratio of 1.00. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
CTAC has a worse Current ratio (1.00) than 64.38% of its industry peers.
CTAC has a Quick Ratio of 1.00. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.00, CTAC is not doing good in the industry: 60.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 351.71% over the past year.
CTAC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.20% yearly.
Looking at the last year, CTAC shows a small growth in Revenue. The Revenue has grown by 0.81% in the last year.
CTAC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.74% yearly.
EPS 1Y (TTM)351.71%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%15.97%
Revenue 1Y (TTM)0.81%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%1.44%

3.2 Future

CTAC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.55% yearly.
The Revenue is expected to grow by 7.12% on average over the next years.
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y5.84%
Revenue Next 5Y7.12%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.10, the valuation of CTAC can be described as very reasonable.
CTAC's Price/Earnings ratio is rather cheap when compared to the industry. CTAC is cheaper than 90.41% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.49. CTAC is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 7.52 indicates a rather cheap valuation of CTAC.
Based on the Price/Forward Earnings ratio, CTAC is valued cheaper than 89.04% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.69. CTAC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.1
Fwd PE 7.52
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CTAC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CTAC is cheaper than 86.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.64
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTAC's earnings are expected to grow with 21.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)0.46
EPS Next 2Y30.93%
EPS Next 3Y21.55%

7

5. Dividend

5.1 Amount

CTAC has a Yearly Dividend Yield of 3.32%. Purely for dividend investing, there may be better candidates out there.
CTAC's Dividend Yield is a higher than the industry average which is at 3.76.
Compared to an average S&P500 Dividend Yield of 2.31, CTAC pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.32%

5.2 History

The dividend of CTAC is nicely growing with an annual growth rate of 17.13%!
Dividend Growth(5Y)17.13%
Div Incr Years0
Div Non Decr Years1
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

CTAC pays out 37.91% of its income as dividend. This is a sustainable payout ratio.
CTAC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP37.91%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

CTAC NV

AMS:CTAC (12/5/2025, 7:00:00 PM)

3.22

-0.09 (-2.72%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.8%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap45.56M
Revenue(TTM)125.22M
Net Income(TTM)4.10M
Analysts85
Price Target2.97 (-7.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.32%
Yearly Dividend0.11
Dividend Growth(5Y)17.13%
DP37.91%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-22.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.1
Fwd PE 7.52
P/S 0.36
P/FCF N/A
P/OCF 19.41
P/B 1.48
P/tB 10.68
EV/EBITDA 4.64
EPS(TTM)0.29
EY9.01%
EPS(NY)0.43
Fwd EY13.3%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.17
OCFY5.15%
SpS8.85
BVpS2.17
TBVpS0.3
PEG (NY)0.24
PEG (5Y)0.46
Graham Number3.76
Profitability
Industry RankSector Rank
ROA 5.74%
ROE 13.36%
ROCE 15.2%
ROIC 7.06%
ROICexc 7.47%
ROICexgc 21.3%
OM 4.54%
PM (TTM) 3.28%
GM 54.86%
FCFM N/A
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
ROICexc(3y)9.86%
ROICexc(5y)10.11%
ROICexgc(3y)93.05%
ROICexgc(5y)116.82%
ROCE(3y)14.76%
ROCE(5y)14.73%
ROICexgc growth 3Y-10.84%
ROICexgc growth 5Y39.25%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y15.11%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
F-Score5
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA 1.02
Cap/Depr 69.4%
Cap/Sales 2.97%
Interest Coverage 14.65
Cash Conversion 21.25%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 3
F-Score5
WACC6.54%
ROIC/WACC1.08
Cap/Depr(3y)40.73%
Cap/Depr(5y)30.86%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.4%
Profit Quality(3y)401.58%
Profit Quality(5y)373.89%
High Growth Momentum
Growth
EPS 1Y (TTM)351.71%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%15.97%
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue 1Y (TTM)0.81%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%1.44%
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y5.84%
Revenue Next 5Y7.12%
EBIT growth 1Y24.33%
EBIT growth 3Y-4.9%
EBIT growth 5Y21.94%
EBIT Next Year66.67%
EBIT Next 3Y25.99%
EBIT Next 5YN/A
FCF growth 1Y-114.47%
FCF growth 3Y-7.01%
FCF growth 5Y0.39%
OCF growth 1Y-79.51%
OCF growth 3Y2.52%
OCF growth 5Y4.91%

CTAC NV / CTAC.AS FAQ

What is the ChartMill fundamental rating of CTAC NV (CTAC.AS) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CTAC.AS.


What is the valuation status of CTAC NV (CTAC.AS) stock?

ChartMill assigns a valuation rating of 7 / 10 to CTAC NV (CTAC.AS). This can be considered as Undervalued.


Can you provide the profitability details for CTAC NV?

CTAC NV (CTAC.AS) has a profitability rating of 4 / 10.


How financially healthy is CTAC NV?

The financial health rating of CTAC NV (CTAC.AS) is 4 / 10.


What is the expected EPS growth for CTAC NV (CTAC.AS) stock?

The Earnings per Share (EPS) of CTAC NV (CTAC.AS) is expected to grow by 46.94% in the next year.